
Targeting Elongation Factor-2 Kinase to Reinforce ...
Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...
Study Goals: Reveal how a molecule called neuritin supports a population of immune cells that actively interferes with the killing of melanomas; determine if ther...
Description: Melanoma of the uveal tract (a region of the eye) is the most common ocular malignancy in adults and accounts for 5% of all melanomas. According to N...
Description: Mutations in a small number of genes are found in a large fraction of human melanomas. For instance, so-called “driver” mutations in the “famous” melan...
Description: Treatment of advanced melanoma with immunotherapy agents shows striking responses in some patients, however overall responses are low. In addition, a significa...
Established Investigator Award – Ashani Weeraratna, PhD
Established Investigator Award – Rutao Cui
Established Investigator Award – Linda Bradley
Established Investigator Award – Dr. Ze’ev Ronai
Established Investigator Award – Dr. Jacqueline Lees
Established Investigator Award – Dr. Eduardo Davila
CURE OM funded Established Investigator – CURE OM – Dr. William Tansey
Oct 16, 2025 ET
Oct 30, 2025 ET